Stock chart
Ticker: DNDNQ Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-02-19 2015-02-19 S Sale

Brophy Karen

VP, Human Resources

Officer
3,823 -6.5%
0.07
USD 270
3,823 -6.5% 0.07 USD 270
2015-02-19 2015-02-19 S Sale

Brophy Karen

VP, Human Resources

Officer
2,309 -3.8%
0.07
USD 167
2,309 -3.8% 0.07 USD 167
2015-02-18 2015-02-18 S Sale

Pacheco Silvio

SVP, Sales and Marketing

Officer
3,222 -3.3%
0.07
USD 222
3,222 -3.3% 0.07 USD 222
2015-02-18 2015-02-17 S Sale

Pacheco Silvio

SVP, Sales and Marketing

Officer
2,500 -2.5%
0.08
USD 203
2,500 -2.5% 0.08 USD 203
2015-02-18 2015-02-17 S Sale

Crotty Robert

EVP, General Counsel

Officer
21,764 -18.2%
0.08
USD 1,765
21,764 -18.2% 0.08 USD 1,765
2015-02-17 2015-02-17 S Sale

Monteith William

EVP, Technical Operations

Officer
96,690 -31.5%
0.08
USD 7,300
96,690 -31.5% 0.08 USD 7,300
2015-02-17 2015-02-13 S Sale

Cox Greg

EVP, CFO & Treasurer

Officer
4,021 -2.2%
0.09
USD 372
4,021 -2.2% 0.09 USD 372
2015-02-17 2015-02-13 S Sale

Sandler Andrew Seth

EVP, Chief Medical Officer

Officer
105,925 -33.8%
0.09
USD 9,470
105,925 -33.8% 0.09 USD 9,470
2015-02-17 2015-02-13 S Sale

Monteith William

EVP, Technical Operations

Officer
1,284 -0.4%
0.09
USD 112
1,284 -0.4% 0.09 USD 112
2015-02-17 2015-02-13 S Sale

Cox Greg

EVP, CFO & Treasurer

Officer
110,133 -37.7%
0.09
USD 10,132
110,133 -37.7% 0.09 USD 10,132
2015-02-17 2015-02-13 S Sale

Sandler Andrew Seth

EVP, Chief Medical Officer

Officer
7,791 -2.4%
0.09
USD 704
7,791 -2.4% 0.09 USD 704
2014-01-10 2013-12-10 S Sale

Rocco Lindsay

EVP, Corporate Communications

Officer
8,207 -6.8%
2.94
USD 24,145
8,207 -6.8% 2.94 USD 24,145
2012-08-02 2012-08-01 B Purchase

CANET GERARDO

Non-Executive Director
10,000 +25.2%
4.38
USD 43,799
10,000 +25.2% 4.38 USD 43,799
2011-11-16 2011-11-14 S Sale

Frohlich Mark W

See General Remarks

Officer
7,500 -4.0%
7.20
USD 53,999
7,500 -4.0% 7.20 USD 53,999
2011-11-07 2011-11-07 B Purchase

SCHIFFMAN GREGORY T

CFO, SVP of Finance & Treasure

Officer
30,030 +14.2%
6.66
USD 200,000
30,030 +14.2% 6.66 USD 200,000
2011-11-07 2011-11-04 B Purchase

JOHNSON JOHN

Non-Executive Director
2,500 +23.9%
6.68
USD 16,689
2,500 +23.9% 6.68 USD 16,689
2011-10-19 2011-10-17 PS Planned sale

URDAL DAVID

SVP, Chief Scientific Officer

Officer
2,036 -0.3%
9.65
USD 19,647
2,036 -0.3% 9.65 USD 19,647
2011-09-13 2011-09-09 B Purchase

BAYH SUSAN B

Non-Executive Director
20,000 +96.4%
11.05
USD 220,958
20,000 +96.4% 11.05 USD 220,958
2011-07-26 2011-07-25 PS Planned sale

GOLD MITCHELL

President & Chief Executive Of

Officer
3,881 -1.7%
38.37
USD 148,900
3,881 -1.7% 38.37 USD 148,900
2011-07-19 2011-07-17 PS Planned sale

URDAL DAVID

SVP, Chief Scientific Officer

Officer
2,035 -0.4%
38.43
USD 78,205
2,035 -0.4% 38.43 USD 78,205
// ... existing code ...